Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04608019 · ClinicalTrials.gov registry record · NA
Streamlined Treatment of Pulmonary Exacerbations in Pediatrics Pilot Study
A NA study, sponsored by University of Washington, the Collaborative Health Studies Coordinating Center.
- Completed
- Registry status
- NA
- Development phase
- 121
- Enrollment target
NCT04608019 is a NA study that has completed, run by University of Washington, the Collaborative Health Studies Coordinating Center. The registered enrollment target is 121 participants.
The verdict
NCT04608019, a NA study, has completed, sponsored by University of Washington, the Collaborative Health Studies Coordinating Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
Study Summary
STOP PEDS is a pilot study of children with CF ages 6-18 across 10 sites in North America. The primary goal is to assess the acceptability and feasibility of a multicenter randomized trial comparing immediate antibiotics versus tailored therapy for pulmonary exacerbation (PEx) treatment in this population.
Interventions
- OTHER Immediate Antibiotics
- OTHER Tailored Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2020-11-10 |
| Est. Completion | 2022-08-18 |
| Phase | NA |
Sponsor
University of Washington, the Collaborative Health Studies Coordinating Center5 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04608019
The ClinicalTrials.gov registry entry for NCT04608019 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, the Collaborative Health Studies Coordinating Center, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Immediate Antibiotics is the first listed.
NCT04608019 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04608019 about?
NCT04608019 is a clinical study titled "Streamlined Treatment of Pulmonary Exacerbations in Pediatrics Pilot Study". STOP PEDS is a pilot study of children with CF ages 6-18 across 10 sites in North America. The primary goal is to assess the acceptability and feasibility of a multicenter randomized trial comparing immediate antibiotics versus tailored therapy for pulmonary exacerbation (PEx) treatment in this popu...
What is the current status of trial NCT04608019?
This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2020-11-10. Estimated completion is 2022-08-18.
What interventions are being tested in trial NCT04608019?
The interventions under investigation include: Immediate Antibiotics (OTHER), Tailored Treatment (OTHER).
Who is sponsoring clinical trial NCT04608019?
This trial is sponsored by University of Washington, the Collaborative Health Studies Coordinating Center, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.